Pharmaceutical Commerce - March/April 2013

Supplier of injectable-drug dispensing system sees new opportunities

The accelerating adoption of electronic health records, e-prescribing and mobile technologies will change the conventions of sample distribution

Web design is tailored to tablets, with scrolling screens and 'native content' for advertisers

Site puts an emphasis on effective referrals and collaboration among physicians

International collaboration emerges as a focus

Next addition is 'already being planned' says divisional VP, Bill Hook

Proportion of cold chain products continues to grow in the biopharma inventory

Virtuwell, operated by a MN healthcare provider, has expanded to three states

The near-takeover of detailing with the Apple iPad has created a springboard for new applications

Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products

In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'

When entering the specialty pharmaceuticals arena, manufacturers need to evaluate the capabilities of their channel partners carefully

Annual Jones Lang LaSalle report ranks US clusters, looks at international activity

Patients, physicians and pharmacists signal their support of copay cards in Alliance Life Sciences study

Number of cases opened by FDA's Office of Criminal Investigations (OCI) triples to 170

As the business grows at double-digit rates, representing its interests becomes its own business opportunity

Like the other war on drugs, there's no end in sight

While awaiting the effects of the Affordable Care Act on PAPs, industry and its service providers wrestle with conflicting priorities

Microneedles and 'active' patches extend the reach of transdermal applications